Latest News about GSK
Recent news which mentions GSK
KVUE Stock: Should You Buy Into the Kenvue IPO?
May 03, 2023
From InvestorPlace
From Benzinga
GSK Stock: A Value Trap or a Hidden Gem?
April 27, 2023
From InvestorPlace
A New Depression Drug Being Developed By Tonix May Side-Step Treatment-Limiting Effects Of Nearly All Current Antidepressants In The US
April 27, 2023
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
April 26, 2023
From Benzinga
3 Biotechs That Might Get Bought Out in 2023
April 26, 2023
From Motley Fool
Was This Acquisition a Savvy Play by This Big Pharma Stock?
April 26, 2023
From Motley Fool
Unlocking Xenon Pharmaceuticals $1B Potential: Analyst Cites Anti-Epileptic Candidate's Untapped Value
April 25, 2023
From Benzinga
Why Shares of Arrowhead Pharmaceuticals Are Up Tuesday
April 25, 2023
From Motley Fool
Johnson & Johnson Unleashes Kenvue: Tylenol to Neutrogena, $40B Revenue Unit Spinoff Preps for IPO Blitz
April 24, 2023
From Benzinga
United Nations' Specialized Agency In Preliminary Talks With Takeda For Dengue Vaccine, Currently Under FDA Review
April 21, 2023
From Benzinga
Why Shares of Bellus Health Skyrocketed This Week
April 20, 2023
From Motley Fool
Why BELLUS Health Stock Is Rocketing Higher Today
April 18, 2023
From Motley Fool
From Benzinga
Bellus Health’s stock climbs on GSK deal, while Goldman Sachs is hurt by a revenue miss
April 18, 2023
From MarketWatch
Why Is Bellus Health (BLU) Stock Up 98% Today?
April 18, 2023
From InvestorPlace
From MarketWatch
GSK To Strengthen Specialty Medicines and Respiratory Pipeline With $2B BELLUS Health Acquisition
April 18, 2023
From Benzinga
GSK to acquire U.S.-based BELLUS Health for $14.75 per share
April 18, 2023
From MarketWatch
Can Pfizer Beat GSK and Moderna in This $10 Billion Market?
April 13, 2023
From Motley Fool
Why Shares of Adaptimmune Therapeutics Jumped Tuesday
April 11, 2023
From Motley Fool
Biden Administration Launches $5B Program To Boost Development Of Pan-Coronavirus Vaccine, Treatments
April 11, 2023
From Benzinga
2 Top Biotech Stocks to Buy in April
April 04, 2023
From Motley Fool
From Motley Fool
Texas Judge Obstructs Affordable Act Coverage Mandate For Some Cancer Screenings, Prophylaxis
March 31, 2023
From Benzinga
Stage Set For Generics As Biden Admin Asks Supreme Court To Hear Skinny Labels Case Between GSK, Teva
March 31, 2023
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.